MTOR and Myocardial fibrosis: It has been also documented that the activation of the PI3K/Akt‐mTOR pathway could inhibit myocardial fibrosis, hypertrophic or dilated cardiomyopathy by blocking myocardial fibrosis and then improving diastolic function.46